Work

Recent Studies on Albomycin, a New Antibiotic

Year: 1955
Type: article
Abstract: Albomycin, a new antibiotic, has been manufactured during recent years by the pharmaceutical industry of the Soviet Union.It has been studied both in the laboratory and in clinical practice, and it is the purpose of this paper to summarize the results of the most impor- tant studies.Origin and Chemical Nature Albomycin was obtained by Gause and Brazhnikova (1951) from cultures of a new species of streptomycetes, Actinomyces suibtropicus.This antibiotic strongly inhibits the growth of Gram-positive cocci, chiefly pneumococcus and staphylococcus.More important, it inhibits the growth of staphylococci resistant to other antibiotics, including penicillin, streptomycin, the tetracyclines, and erythromycin.It is also effective against a number of Gram-negative bac- teria-for instance, the coli-dysentery group of organisms and Friedlander's bacillus.Pure albomycin inhibits the growth of staphylococci in a dilution of 1 in 700 millions, whereas crystalline penicillin inhibits their growth in a dilu- tion of 1 in 80 millions.In other words, 1 mg. of albomycin inhibits the growth of staphylococci about ten times more strohgly than an equal amount of penicillin.Albomycin was found to be practically non-toxic for animals and in clinical practice, and it was therefore studied in greater
Source: BMJ
Author: G. F. Gause
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W1984956671
FWCI: 13.26
Cites: 2
Cited by: 137
Related to: 10